Call: 07971891562( PIN:244)
Send Inquiry
Send Inquiry40 mg Adalirel Adalimumab Injection
Price 8500 INR/ Unit
MOQ : 1 Unit
40 mg Adalirel Adalimumab Injection Trade Information
- Minimum Order Quantity
- 1 Unit
- Payment Terms
- Cash Advance (CA)
- Delivery Time
- 7 Days
- Main Domestic Market
- All India
About 40 mg Adalirel Adalimumab Injection
We are actively engaged in offering 40 mg Adalirel Adalimumab Injection, which are approved for Rheumatoid Arthritis, Crohns disease, Ulcerative Colitis, Psoriatic Arthritis, Ankylosing Spondylitis and moderate to severe chronic psoriasis. Apart from this, 40 mg Adalirel Adalimumab Injection is an anti -inflammatory, Tumor Necrosis Factor (TNF) binding biological medicine. Customers can purchase this injection in bulk orders within given time frame.FAQs of 40 mg Adalirel Adalimumab Injection:
Q: What is the drug type of 40 mg Adalirel Adalimumab Injection?
A: The drug type of 40 mg Adalirel Adalimumab Injection is an injection.Q: What is the physical form of the 40 mg Adalirel Adalimumab Injection?
A: The physical form is liquid.Q: What is the dosage guideline for 40 mg Adalirel Adalimumab Injection?
A: The dosage guideline is as per prescription.Q: What is the quantity provided in each box of 40 mg Adalirel Adalimumab Injection?
A: Each box contains 0.4 ml.Q: What is the dosage strength of this product?
A: The dosage strength is 40 mg.
More Products in 40mg Adalimumab Injection Category
40 mg Adalimumab Injection
Price 8500 INR / Unit
Minimum Order Quantity : 1 Unit
Composition : adalimumab
Physical Form : Liquid
Age Group : Adult
Packaging : Other
Exemptia Adalimumab Injection
Price 8000 INR / Bottle
Minimum Order Quantity : 1 Bottle
Composition : Adalimumab (40mg/0.8ml)
Physical Form : Capsules
Age Group : Suitable For All Ages
Packaging : Bottle Pack
Contact Details
PHARMA BROTHERS
GST : 10AAWFP9077C1ZZ
- B No.F-15, Mahima Palace, Govind Mitra Road, Patna - 800004, Bihar, India
- Phone :View Number
Send Inquiry
Developed and Managed by Infocom Network Private Limited.
